Essence Chamber
On sale on the US market (according to the DSLD)
Health Concerns, food supplement from the US market
Essence Chamber (Health Concerns), a food supplement au code-barres 810034440563, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Health Concerns
- Barcode
- 810034440563
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Hypromellose, Rice Bran
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Herbal Blend | Blend | 2,250 mg |
| Patrinia Whole Plant Extract | Plant | not stated |
| Saw Palmetto berry extract (Serenoa repens) | Plant | not stated |
| Salvia Root Extract | Plant | not stated |
| Cow Cockle Seed Extract | Plant | not stated |
| Uva-Ursi leaf extract (Arctostaphylos uva-ursi) | Plant | not stated |
| Hydrangea (Hydrangea arborescens) | Plant | not stated |
| Damiana (Turnera diffusa) | Plant | not stated |
| Poria sclerotium extract | Plant | not stated |
| Tokoro Yam Rhizome Extract | Plant | not stated |
| Pumpkin Seed Extract (Cucurbita pepo) | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Essence Chamber
Entered into DSLD on 25 April 2017. On sale on the US market (according to the DSLD).- Active ingredient added : Abutilon (quantity not stated)
- Active ingredient added : Liquidambar (quantity not stated)
- Active ingredient added : Patrinia (quantity not stated)
- Active ingredient added : Poria sclerotium (quantity not stated)
- Active ingredient added : Proprietary Blend (750 mg)
- Active ingredient added : Salvia (quantity not stated)
- Active ingredient added : Saw Palmetto fruit concentrate (quantity not stated)
- Active ingredient added : Tokoro (quantity not stated)
- Active ingredient added : Vaccaria (quantity not stated)
- Active ingredient removed : Cow Cockle Seed Extract (quantity not stated)
- Active ingredient removed : Patrinia Whole Plant Extract (quantity not stated)
- Active ingredient removed : Poria sclerotium extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (2,250 mg)
- Active ingredient removed : Pumpkin Seed Extract (quantity not stated)
- Active ingredient removed : Salvia Root Extract (quantity not stated)
- Active ingredient removed : Saw Palmetto berry extract (quantity not stated)
- Active ingredient removed : Tokoro Yam Rhizome Extract (quantity not stated)
- Active ingredient removed : Uva-Ursi leaf extract (quantity not stated)
Official label: Essence Chamber
Entered into DSLD on 25 April 2017. On sale on the US market (according to the DSLD).- Active ingredient added : Abutilon (quantity not stated)
- Active ingredient added : Liquidambar (quantity not stated)
- Active ingredient added : Patrinia (quantity not stated)
- Active ingredient added : Poria sclerotium (quantity not stated)
- Active ingredient added : Proprietary Blend (750 mg)
- Active ingredient added : Salvia (quantity not stated)
- Active ingredient added : Saw Palmetto fruit concentrate (quantity not stated)
- Active ingredient added : Tokoro (quantity not stated)
- Active ingredient added : Vaccaria (quantity not stated)
- Active ingredient removed : Cow Cockle Seed Extract (quantity not stated)
- Active ingredient removed : Patrinia Whole Plant Extract (quantity not stated)
- Active ingredient removed : Poria sclerotium extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (2,250 mg)
- Active ingredient removed : Pumpkin Seed Extract (quantity not stated)
- Active ingredient removed : Salvia Root Extract (quantity not stated)
- Active ingredient removed : Saw Palmetto berry extract (quantity not stated)
- Active ingredient removed : Tokoro Yam Rhizome Extract (quantity not stated)
- Active ingredient removed : Uva-Ursi leaf extract (quantity not stated)
Official label: Essence Chamber
Entered into DSLD on 25 September 2013. Withdrawn from the US market on 21 March 2017 (according to the DSLD).- Active ingredient added : Abutilon (quantity not stated)
- Active ingredient added : Liquidambar (quantity not stated)
- Active ingredient added : Patrinia (quantity not stated)
- Active ingredient added : Poria sclerotium (quantity not stated)
- Active ingredient added : Salvia (quantity not stated)
- Active ingredient added : Saw Palmetto fruit concentrate (quantity not stated)
- Active ingredient added : Tokoro (quantity not stated)
- Active ingredient added : Vaccaria (quantity not stated)
- Active ingredient removed : Cow Cockle Seed Extract (quantity not stated)
- Active ingredient removed : Patrinia Whole Plant Extract (quantity not stated)
- Active ingredient removed : Poria sclerotium extract (quantity not stated)
- Active ingredient removed : Pumpkin Seed Extract (quantity not stated)
- Active ingredient removed : Salvia Root Extract (quantity not stated)
- Active ingredient removed : Saw Palmetto berry extract (quantity not stated)
- Active ingredient removed : Tokoro Yam Rhizome Extract (quantity not stated)
- Active ingredient removed : Uva-Ursi leaf extract (quantity not stated)
- Same quantity, different name: Proprietary Blend in this version; Proprietary Herbal Blend on the displayed label (2,250 mg)
- Different unit, without conversion : Damiana: quantity not stated in this version; quantity not stated on the displayed label
- Different unit, without conversion : Hydrangea: quantity not stated in this version; quantity not stated on the displayed label
Official label: Essence Chamber
Entered into DSLD on 25 September 2013. Withdrawn from the US market on 21 March 2017 (according to the DSLD).- Active ingredient added : Abutilon (quantity not stated)
- Active ingredient added : Liquidambar (quantity not stated)
- Active ingredient added : Patrinia (quantity not stated)
- Active ingredient added : Poria sclerotium (quantity not stated)
- Active ingredient added : Salvia (quantity not stated)
- Active ingredient added : Saw Palmetto fruit concentrate (quantity not stated)
- Active ingredient added : Tokoro (quantity not stated)
- Active ingredient added : Vaccaria (quantity not stated)
- Active ingredient removed : Cow Cockle Seed Extract (quantity not stated)
- Active ingredient removed : Patrinia Whole Plant Extract (quantity not stated)
- Active ingredient removed : Poria sclerotium extract (quantity not stated)
- Active ingredient removed : Pumpkin Seed Extract (quantity not stated)
- Active ingredient removed : Salvia Root Extract (quantity not stated)
- Active ingredient removed : Saw Palmetto berry extract (quantity not stated)
- Active ingredient removed : Tokoro Yam Rhizome Extract (quantity not stated)
- Active ingredient removed : Uva-Ursi leaf extract (quantity not stated)
- Same quantity, different name: Proprietary Blend in this version; Proprietary Herbal Blend on the displayed label (2,250 mg)
- Different unit, without conversion : Damiana: quantity not stated in this version; quantity not stated on the displayed label
- Different unit, without conversion : Hydrangea: quantity not stated in this version; quantity not stated on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Saw Palmetto berry extract
Read the warning, when it applies and the studies cited
SAW PALMETTO – SERENOA REPENS
Route of administration: Oral
Cautions and warnings
Condition of application: All subpopulations.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Adult males only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.
Condition of application: Adult females only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
Contraindications
Condition of application: Adult females only.
Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
- Uva-Ursi leaf extract
Read the warning, when it applies and the studies cited
Bearberry - Arctostaphylos Uva-Ursi
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Applies to products providing 60 milligrams or more of dried leaves and/or products providing 20 milligrams or more of Arbutin, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder, fever, painful urination (dysuria), spasms, or blood in urine (EMA 2018; Duke 2002; Newall 1996).
Sources cited by Health Canada (2)
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A guide for health-care professionals. London (GB): The Pharmaceutical Press; 1996.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (EMA 2018; Brinker 2010; ESCOP 2003; WHO 2002; Blumenthal 2000; Mills and Bone 2000; Bradley 1992).
Sources cited by Health Canada (8)
- Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- Bradley PR, editor. British Herbal Compendium Volume 1: A Handbook of Scientific Information on Widely Used Plant Drugs - Companion Volume 1 of the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 1992.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018: EMA/HMPC/750269/2016. European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium. London (GB): European Medicines Agency: Committee on Herbal Medicinal Products (HMPC); 2018 January 30. [Accessed 2024 June 11]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-arctostaphylos-uva-ursi-l-spreng-folium-revision-2_en.pdf
- ESCOP 2003: European Scientific Cooperative of Phytotherapy. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition completely revised and expanded. Exeter (GB): European Scientific Cooperative on Phytotheraphy; 2003.
- Mills S, Bone K. Principles and Practice of Phytotherapy, Modern Herbal Medicine. Edinburg (GB): Churchill LYes Soivingston; 2000.
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 3. Geneva (CH): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 3. Genève (CH): Organisation mondiale de la santé; 2002.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Health Concerns
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Essence Chamber (Health Concerns): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/810034440563-essence-chamber-health-concerns, updated 22 January 2022.